This HTML5 document contains 153 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dbpedia-dehttp://de.dbpedia.org/resource/
n23http://uz.dbpedia.org/resource/
dctermshttp://purl.org/dc/terms/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n27http://www.kyowa-kirin.co.jp/english/
n24https://global.dbpedia.org/id/
schemahttp://schema.org/
dbpedia-ruhttp://ru.dbpedia.org/resource/
dbthttp://dbpedia.org/resource/Template:
rdfshttp://www.w3.org/2000/01/rdf-schema#
n28http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#
n10http://www.kyowa-kirin.com/
n26http://viaf.org/viaf/
n4http://commons.wikimedia.org/wiki/Special:FilePath/
dbpedia-fahttp://fa.dbpedia.org/resource/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
wikipedia-enhttp://en.wikipedia.org/wiki/
dbpedia-mshttp://ms.dbpedia.org/resource/
dbphttp://dbpedia.org/property/
dbchttp://dbpedia.org/resource/Category:
provhttp://www.w3.org/ns/prov#
xsdhhttp://www.w3.org/2001/XMLSchema#
dbpedia-idhttp://id.dbpedia.org/resource/
wikidatahttp://www.wikidata.org/entity/
dbrhttp://dbpedia.org/resource/
dbpedia-jahttp://ja.dbpedia.org/resource/
n25http://d-nb.info/gnd/

Statements

Subject Item
dbr:Kyowa_Kirin
rdf:type
dbo:Agent dbo:Organisation schema:Organization wikidata:Q43229 wikidata:Q4830453 wikidata:Q24229398 owl:Thing dbo:Company n28:Agent n28:SocialPerson
rdfs:label
Kyowa Kirin Kyowa Kirin Kyowa Kirin Kyōwa Hakkō Kirin 協和キリン
rdfs:comment
Kyowa Kirin Co., Ltd. (協和キリン株式会社 Kyōwa Kirin Kabushiki Kaisha) adalah perusahaan farmasi dan bioteknologi Jepang di bawah Kirin Holdings, dan termasuk di antara 40 pendapatan terbesar di dunia. Perusahaan ini berkantor pusat di Chiyoda-ku, Tokyo dan merupakan anggota indeks saham Nikkei 225. Kyowa Kirin — японская фармацевтическая компания, дочерняя структура пивоваренной группы Kirin Holdings (ей принадлежит 53,4 % акций).. 協和キリン株式会社(きょうわキリン)は、医療用医薬品事業等を行う、製薬企業である。かつては、日本酒・焼酎・ワインの製造を手掛ける酒造メーカーでもあった。キリンホールディングスの子会社で、キリングループに属する。日経平均株価の構成銘柄の一つ。 Kyowa Kirin Co., Ltd. (協和キリン株式会社, Kyōwa Kirin Kabushiki Kaisha) is a Japanese pharmaceutical and biotechnology company under the Kirin Holdings, and is among the 40 largest in the world by revenue. The company is headquartered in Chiyoda-ku, Tokyo and is a member of the Nikkei 225 stock index. Kyōwa Hakkō Kirin K.K. (jap. 協和発酵キリン株式会社, ~ Kabushiki kaisha, engl. Kyowa Hakko Kirin Co., Ltd.) ist ein japanischer Pharmakonzern. Er entstand 2008 durch Zusammenschluss von Kyōwa Hakkō Kōgyō K.K. (協和醱酵工業株式会社) und Kirin Pharma K.K. (キリンファーマ株式会社). Zu Kyōwa Hakkō gehören die internationalen Tochterunternehmen KH Neochem und ProStrakan.
foaf:name
Kyowa Kirin Co., Ltd.
foaf:homepage
n10:index.html
dbp:name
Kyowa Kirin Co., Ltd.
foaf:depiction
n4:Kyowa_Hakko_Kirin_Logo.svg n4:大手町フィナンシャルシティグランキューブ.jpg
dbo:location
dbr:Japan dbr:Ōtemachi dbr:Chiyoda,_Tokyo dbr:Tokyo
dcterms:subject
dbc:Pharmaceutical_companies_established_in_1949 dbc:Biopharmaceutical_companies dbc:Pharmaceutical_companies_based_in_Tokyo dbc:Pharmaceutical_companies_of_Japan dbc:Japanese_brands dbc:Companies_listed_on_the_Tokyo_Stock_Exchange dbc:Biotechnology_companies_of_Japan dbc:1949_establishments_in_Japan
dbo:wikiPageID
27406017
dbo:wikiPageRevisionID
1124571476
dbo:wikiPageWikiLink
dbr:Plant_growth_regulators dbr:Biotechnology dbr:FUT8 dbr:Tokyo dbr:Nucleic_acids dbr:Biochemicals dbc:Pharmaceutical_companies_established_in_1949 dbr:US_dollar dbr:Fiscal_year dbr:Oncology dbr:Vitamins dbr:Public_Company dbr:Chinese_hamster_ovary_cell dbr:Kyowa_Hakko_Kogyo_Co.,_Ltd dbr:Allergy dbr:Nikkei_225 dbr:Biotechnology_company dbr:Reagents dbr:Pharmaceutical_company dbc:Pharmaceutical_companies_of_Japan dbc:Biopharmaceutical_companies dbr:Central_nervous_system dbr:CEO dbr:Kabushiki_gaisha dbr:Grünenthal dbr:Japan dbc:Japanese_brands dbc:Pharmaceutical_companies_based_in_Tokyo dbr:President_(corporate_title) dbr:Biosimilars dbr:Kirin_Company dbr:Diagnostics dbr:Chiyoda,_Tokyo dbr:Immunology dbr:Nephrology dbr:Ōtemachi dbr:Mogamulizumab dbr:Peptides dbc:Companies_listed_on_the_Tokyo_Stock_Exchange dbr:Amino_acids dbc:Biotechnology_companies_of_Japan dbr:Pharmaceuticals dbr:Kirin_Brewery_Company dbr:Novo_Nordisk_Foundation dbr:Japanese_yen dbc:1949_establishments_in_Japan dbr:Afucosylated_monoclonal_antibodies
dbo:wikiPageExternalLink
n27:index.html n10:index.html
owl:sameAs
dbpedia-fa:کیووا_کیرین dbpedia-ms:Kyowa_Kirin dbpedia-de:Kyōwa_Hakkō_Kirin dbpedia-id:Kyowa_Kirin dbpedia-ru:Kyowa_Kirin dbpedia-ja:協和キリン n23:Kyowa_Kirin n24:4q9Rj n25:10047618-1 wikidata:Q6452254 n26:134651517
dbp:wikiPageUsesTemplate
dbt:Infobox_company dbt:Nihongo dbt:Nikkei_225 dbt:Portal dbt:TYO dbt:Profit dbt:Authority_control dbt:Reflist
dbo:thumbnail
n4:Kyowa_Hakko_Kirin_Logo.svg?width=300
dbp:foundation
1949-07-01
dbp:homepage
n10:index.html
dbp:industry
dbr:Biotechnology dbr:Pharmaceuticals
dbp:keyPeople
Nobuo Hanai,
dbp:location
Ohtemachi Building, 1-6-1, Ōtemachi, Chiyoda-ku, Tokyo 100-8185, Japan
dbp:logo
Kyowa Hakko Kirin Logo.svg
dbp:logoSize
200
dbp:netIncome
$ 31.32 million USD
dbp:numEmployees
7532
dbp:parent
dbr:Kirin_Company
dbp:products
dbr:Biochemicals dbr:Pharmaceuticals dbr:Biosimilars dbr:Diagnostics
dbp:revenue
$ 3.548 billion USD
dbp:subsid
47
dbp:tradedAs
FWB:KY4 dbr:Nikkei_225
dbp:type
Public
dbo:abstract
Kyōwa Hakkō Kirin K.K. (jap. 協和発酵キリン株式会社, ~ Kabushiki kaisha, engl. Kyowa Hakko Kirin Co., Ltd.) ist ein japanischer Pharmakonzern. Er entstand 2008 durch Zusammenschluss von Kyōwa Hakkō Kōgyō K.K. (協和醱酵工業株式会社) und Kirin Pharma K.K. (キリンファーマ株式会社). Kyōwa Hakkō Kirin patentierte Hydrotalkit für medizinische Anwendungen (Talcid) und erfand das Fermentationsverfahren zur Mononatriumglutamat-Herstellung. Wichtige Arzneimittel sind z. B. Istradefyllin, Loracarbef und , einem monoklonalen Antikörper zur Behandlung der Adulten T-Zell-Leukämie. Auch der Wachstumsregulator Forchlorfenuron wurde von Kyōwa Hakkō entwickelt. Zu Kyōwa Hakkō gehören die internationalen Tochterunternehmen KH Neochem und ProStrakan. Kyowa Kirin — японская фармацевтическая компания, дочерняя структура пивоваренной группы Kirin Holdings (ей принадлежит 53,4 % акций).. Kyowa Kirin Co., Ltd. (協和キリン株式会社 Kyōwa Kirin Kabushiki Kaisha) adalah perusahaan farmasi dan bioteknologi Jepang di bawah Kirin Holdings, dan termasuk di antara 40 pendapatan terbesar di dunia. Perusahaan ini berkantor pusat di Chiyoda-ku, Tokyo dan merupakan anggota indeks saham Nikkei 225. Kyowa Kirin Co., Ltd. (協和キリン株式会社, Kyōwa Kirin Kabushiki Kaisha) is a Japanese pharmaceutical and biotechnology company under the Kirin Holdings, and is among the 40 largest in the world by revenue. The company is headquartered in Chiyoda-ku, Tokyo and is a member of the Nikkei 225 stock index. 協和キリン株式会社(きょうわキリン)は、医療用医薬品事業等を行う、製薬企業である。かつては、日本酒・焼酎・ワインの製造を手掛ける酒造メーカーでもあった。キリンホールディングスの子会社で、キリングループに属する。日経平均株価の構成銘柄の一つ。
prov:wasDerivedFrom
wikipedia-en:Kyowa_Kirin?oldid=1124571476&ns=0
dbo:wikiPageLength
6724
dbo:foundingDate
1949-07-01
dbo:foundingYear
1949-01-01
dbo:numberOfEmployees
7532
dbo:revenue
3.548E9 3.4061E11
dbo:industry
dbr:Biotechnology dbr:Pharmaceuticals
dbo:keyPerson
dbr:President_(corporate_title) dbr:CEO
dbo:parentCompany
dbr:Kirin_Company
dbo:product
dbr:Diagnostics dbr:Pharmaceuticals dbr:Biosimilars dbr:Biochemicals
dbo:type
dbr:Public_Company
foaf:isPrimaryTopicOf
wikipedia-en:Kyowa_Kirin